We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » CHMP Recommends 14 Approvals, Including GSK’s Apretude, 7 Cancer Treatments
CHMP Recommends 14 Approvals, Including GSK’s Apretude, 7 Cancer Treatments
The European Medicines Agency’s (EMA) human medicines committee (CHMP) recommended 14 medicines for market authorization during its July meeting including GSK’s Apretude (cabotegravir) for HIV, seven cancer treatments and a drug for relapsing multiple sclerosis.